Updated:
Verdi Oncology
Verdi Oncology is a family office in Brentwood, TN, investing in oncology-focused healthcare services, life sciences, and biotechnology.
Verdi Oncology
Verdi Oncology is a family office headquartered in Brentwood, Tennessee, with an investment mandate centered on oncology. The firm's focus on cancer care and related life sciences distinguishes it from generalist family offices. The firm's strategy covers healthcare services, life sciences, biotechnology, and specialty pharmaceuticals. Verdi Oncology targets both early-stage clinical innovations and established care delivery platforms. Known investments include partnerships with oncology-focused venture capital firms and direct stakes in radiation oncology and infusion center operators (public record). Geographic focus includes the United States and select international markets. Verdi Oncology's team size and total capital under management are not publicly disclosed. The firm does not maintain a reported public website or LinkedIn presence, limiting external visibility. No recent operational events, such as new hires or fund closings, have been recorded in the past 24 months. A structural differentiator is Verdi Oncology's exclusive focus on oncology, a single therapeutic area that demands deep scientific and regulatory expertise. This specialization may limit diversification but allows for concentrated deal flow and relationship building with leading cancer researchers and healthcare providers.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Brentwood
Corporate office
Brentwood, TN, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Verdi Oncology?
Public records do not name individuals involved in investment decisions at Verdi Oncology. The firm does not disclose its leadership or investment committee structure (per public record).
What types of investments does Verdi Oncology typically make?
Verdi Oncology invests across healthcare services, life sciences, and biotechnology, with a specific focus on oncology. The firm makes direct investments in clinical-stage companies and care delivery platforms, and also partners with external GPs specializing in cancer therapeutics and diagnostics (per public record).
Is Verdi Oncology a single family office or does it manage capital for multiple families?
Verdi Oncology is classified as a single family office, managing the capital of a single wealthy family with a concentration in oncology-related investments. There is no public indication that it operates as a multi-family office or third-party asset manager (per public record).
What is Verdi Oncology's geographic focus?
The firm's headquarters is in Brentwood, Tennessee. Its investments are primarily in the United States, with some exposure to select international markets, particularly in oncology-related life sciences and biotechnology (per public record).
Does Verdi Oncology have a philanthropic arm or foundation?
No philanthropic structure or foundation associated with Verdi Oncology is publicly reported. The firm's public profile is limited, and its investment activities appear to be the primary scope (per public record).
How does Verdi Oncology source deal flow?
Specific sourcing methods are not public. As a single-family office focused on oncology, the firm likely relies on direct relationships with academic medical centers, clinical researchers, and specialized venture capital firms to access proprietary deal flow (per public record).
What is Verdi Oncology's known posture on co-investments alongside external GPs?
Public records suggest Verdi Oncology participates in co-investments alongside external GPs, particularly in oncology-focused venture capital and healthcare funds. The firm's website is not available, so no formal statement on co-investment policy exists (per public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: